Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta‐analysis

Franco, Juan VA; Jung, Jae Hung; Imamura, Mari; Borofsky, Michael S.; Omar, Muhammad Imran; Liquitay, Camila Micaela Escobar; Young, Shamar; Golzarian, Jafar; Veroniki, Areti Angeliki; Garegnani, Luis; Dahm, Philipp

doi:10.1111/bju.15653

Cited by 26 publications

(23 citation statements)

References 83 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The patient had an IPSS of 29 points and a QOL score of 6. Transrectal ultrasonography revealed a 45-cm 3 PV. The patient had respiratory dysfunction due to chronic obstructive pulmonary disease, and after discussing various surgical options with him, he preferred PUL surgery under local anesthesia.…”

Section: Case Presentationmentioning

confidence: 98%

Two cases of pelvic hematoma after prostatic urethral lift surgery

Fujishima,

Furuta,

Kawamura

et al. 2023

IJU Case Reports

View full text Add to dashboard Cite

IntroductionThere are few reports of pelvic hematoma after prostatic urethral lift. Here, we report two cases of pelvic hematoma in Japan.Case presentationThe first case was a 71‐year‐old man with benign prostatic hyperplasia who underwent prostatic urethral lift. Although the procedure was uneventful, he experienced lower abdominal pain the day after the operation. CT revealed a hematoma in the right pelvis; however, it was manageable with conservative treatment. The second case was a 68‐year‐old man. The procedure was uneventful; however, 6 days after the operation, a subcutaneous hematoma appeared in the lower abdomen. CT revealed a hematoma in the left pelvis. We then performed pelvic hematoma removal surgery.ConclusionsPelvic hematomas after PUL may requires attention, particularly in men with the narrow pelvises. Appropriate compression of the prostate and a high lithotomy position procedure could effectively avoid the occurrence of pelvic hematomas.

show abstract

Section: Case Presentationmentioning

confidence: 98%

Two cases of pelvic hematoma after prostatic urethral lift surgery

Fujishima,

Furuta,

Kawamura

et al. 2023

IJU Case Reports

View full text Add to dashboard Cite

show abstract

“…External stakeholders highlighted the need for reviews on minimally invasive treatments and desmopressin for lower urinary tract symptoms, for which there is a suite of Cochrane reviews [20,[22][23][24][25][26]. The CRG strategy for dissemination was co-publication of those reviews [22,[27][28][29], which has been shown to improve the impact of Cochrane reviews by reaching a highly specialized readership [30]. Moreover, both reviews have been cited in clinical practice guidelines.…”

Section: Final Editorial Prioritizationmentioning

confidence: 99%

Quick prioritization of Cochrane reviews on benign conditions of the prostate

Franco

Jung

Dahm

2023

Cochrane Evidence Synthesis and Methods

Self Cite

View full text Add to dashboard Cite

Introduction: Benign conditions of the prostate include benign prostatic enlargement and prostatitis, which constitute an important cause of morbidity in men.Objective: We aimed to generate a list of priority topics of interest to our external stakeholders within our editorial scope.Methods: Following Cochrane's guidance, we developed a tiered approach for consulting internal and external stakeholders, including members from Urological societies. First, we analyzed our portfolio, including different impact measurements, to assess the need for updates. Then, following criteria related to the feasibility, novelty and relevance of prospective topics for evidence synthesis, we narrowed the list to a suite of titles for updates or new reviews.Results: Twelve editors provided initial feedback as to what the priorities were for updating existing reviews and for new reviews in our portfolio. The editors identified gaps in our portfolio, mainly covering new treatments for benign prostatic hyperplasia. Then we consulted external stakeholders obtaining 30 responses from 14 countries. These stakeholders provided additional information about the relative importance of existing topics and suggested new ones. We identified that many of the latter were already covered in our portfolio, highlighting gaps in their dissemination. Finally, we narrowed down four priority topics that the editorial group will take forward and two additional topics that might need other considerations before being commissioned.Conclusions: Following Cochrane's guidance on priority setting, we identified topics relevant to our editors and external stakeholders by analysing our portfolio and two rounds of surveys. Moreover, we identified opportunities for disseminating existing reviews. Further evaluation is needed of the following up commissioning process for priority reviews.

show abstract

“…Minimally invasive treatments result in broadly similar or less improvement in urinary symptoms and quality of life compared with TURP in men with BPE having moderate to severe symptoms as per a Cochrane network meta-analysis published in 2021 (27 randomised controlled trials, 3017 patients)910 (fig 2). Among minimally invasive procedures, PUL and prostatic artery embolisation (PAE) are likely to be more effective in reducing urinary symptoms.…”

Section: What Is the Evidence Of Uncertainty?mentioning

confidence: 99%

“…Retreatment rates with TURP tend to be lower overall (12 per 1000) compared with minimally invasive therapies. Higher retreatment rates were reported with transurethral microwave therapy (TUMT) 910…”

Section: What Is the Evidence Of Uncertainty?mentioning

confidence: 99%